"If the DSMB reports that the clinical trial is likely to meet its endpoint and that they should continue the trial, CytoDyn will likely immediately apply for Emergency Use Authorization from the FDA."

From Zerohedge^^^

So maybe the will or did apply for EAU?

I know that alone can slow enrollment so dboutful but couldn’t it also get us exposure, maybe it actually speeds up enrollment?

I don’t see how this can’t happen still. Makes sense to do it. Then again tho is just imo...